Safety and efficacy of SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy and/or cetuximab after failure of prior tyrosine kinase inhibitor in non-small cell lung cancer: non-clinical mouse model and phase I/IIa clinical study
- J. Immunother. Cancer, Mar 27 2024, 12 (3) e008585 | https://doi.org/10.1136/jitc-2023-008585